Skip to main content

An update on an incident involving one of our systems

Hide
Quest Diagnostics

High Levels of Myeloperoxidase are Similar Across ASCVD Risk Groups and are Associated with Markers of Liver Fibrosis and Kidney Function in a Workforce Population

AHA 2021: Scientific Sessions if the American Heart Association
Nashville, TN, November 13-15, 2021

High Levels of Myeloperoxidase are Similar Across ASCVD Risk Groups and are Associated with Markers of Liver Fibrosis and Kidney Function in a Workforce Population

Authors: Iakoubova OA, Judy Louie, Shiffman D, McPhaul MJ, Penn MS,

Specialties: Endocrinology, Cardiovascular disease

Download key summary

Related content

Publication
Association between liver and chronic kidney disease on hemoglobin A1c concentrations
On-Demand Webinar
The Continuum of Kidney Disease Care: From Identification to referral
Test FAQ
Kidney Profile
Publication
Differences in HDL-Bound Apolipoproteins in Patients with Advanced Liver Fibrosis due to Nonalcoholic Fatty Liver Disease

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only. May include AI-generated and/or AI-modified imagery.